首页> 外文期刊>Molecular cancer therapeutics >Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity.
【24h】

Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity.

机译:低氧诱导的对抗癌药的耐药性与衰老降低有关,并且需要低氧诱导因子-1活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Hypoxia in solid tumors is associated with the development of chemoresistance. Although many studies have focused on the effect of hypoxia on drug-induced apoptosis, the effect of nonapoptotic pathways on hypoxia-induced drug resistance has not been previously investigated. Here, we determined the effects of hypoxia on multiple forms of drug-induced death in human MDA-MB-231 breast carcinoma cells. Clonogenic assays showed that preexposure to hypoxia leads to resistance to various classes of chemotherapeutic agents, including anthracyclines (daunorubicin and doxorubicin), epipodophyllotoxins (etoposide), and anthracenediones (mitoxantrone). Results revealed a high degree of heterogeneity in nuclear and cytoplasmic alterations in response to acute drug exposure; however, the majority of exposed cells displayed morphologic and biochemical changes consistent with drug-induced senescence. Hypoxia decreased only the proportion of cells in the senescent population, whereas the small proportion of cells exhibiting features of apoptosis or mitotic catastrophe were unaffected. Similar results were obtained with human HCT116 colon carcinoma cells, indicating that the protective effect of hypoxia on drug-induced senescence is not unique to MDA-MB-231 cells. Treatment of MDA-MB-231 cells with small interfering RNA targeting the alpha-subunit of hypoxia-inducible factor-1 (HIF-1), a key regulator of cellular adaptations to hypoxia, prevented hypoxia-induced resistance. HIF-1alpha small interfering RNA also selectively abolished the hypoxia-induced changes in the senescent population, indicating that the increased survival was due to protection against drug-induced senescence. These results support a requirement for HIF-1 in the adaptations leading to drug resistance and reveal that decreased drug-induced senescence is also an important contributor to the development of hypoxia-induced resistance.
机译:实体瘤中的缺氧与化学抗性的发展有关。尽管许多研究集中于缺氧对药物诱导的细胞凋亡的影响,但以前尚未研究非凋亡途径对缺氧诱导的药物耐药性的影响。在这里,我们确定了缺氧对人MDA-MB-231乳腺癌细胞中多种形式的药物诱导的死亡的影响。克隆试验表明,预先暴露于缺氧会导致对各种化学治疗剂产生抗性,包括蒽环类药物(柔红霉素和阿霉素),表鬼臼毒素(依托泊苷)和蒽二酮(米托蒽醌)。结果显示,在急性药物暴露后,核和细胞质变化高度不均一。然而,大多数暴露的细胞显示出与药物诱导的衰老一致的形态和生化变化。缺氧仅降低衰老群体中的细胞比例,而表现出凋亡或有丝分裂灾难特征的小比例细胞则不受影响。用人HCT116结肠癌细胞获得了相似的结果,表明低氧对药物诱导的衰老的保护作用并非MDA-MB-231细胞独有。用靶向低氧诱导因子-1(HIF-1)的α-亚基(细胞对低氧适应的关键调节剂)的小干扰RNA处理MDA-MB-231细胞,可预防低氧诱导的耐药性。 HIF-1alpha小干扰RNA还选择性地消除了低氧引起的衰老人群的变化,这表明存活率的提高是由于对药物诱导的衰老的保护所致。这些结果支持了在导致耐药性的适应过程中对HIF-1的需求,并揭示了降低的药物诱导的衰老也是导致缺氧诱导的耐药性发展的重要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号